ID   LOX15_HUMAN             Reviewed;         662 AA.
AC   P16050; A8K2P4; B7ZA11; Q8N6R7; Q99657;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   15-MAR-2017, entry version 176.
DE   RecName: Full=Arachidonate 15-lipoxygenase;
DE            Short=15-LOX;
DE            Short=15-LOX-1;
DE            EC=1.13.11.33 {ECO:0000269|PubMed:17052953, ECO:0000269|PubMed:1944593};
DE   AltName: Full=12/15-lipoxygenase;
DE   AltName: Full=Arachidonate 12-lipoxygenase, leukocyte-type;
DE            Short=12-LOX;
DE            EC=1.13.11.31 {ECO:0000269|PubMed:1944593};
DE   AltName: Full=Arachidonate omega-6 lipoxygenase;
GN   Name=ALOX15; Synonyms=LOG15;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION.
RX   PubMed=3202857; DOI=10.1016/S0006-291X(88)80271-7;
RA   Sigal E., Craik C.S., Highland E., Grunberger D., Costello L.L.,
RA   Dixon R.A.F., Nadel J.A.;
RT   "Molecular cloning and primary structure of human 15-lipoxygenase.";
RL   Biochem. Biophys. Res. Commun. 157:457-464(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9224951; DOI=10.1016/S0167-4781(97)00005-5;
RA   Kritzik M.R., Ziober A.F., Dicharry S., Conrad D.J., Sigal E.;
RT   "Characterization and sequence of an additional 15-lipoxygenase
RT   transcript and of the human gene.";
RL   Biochim. Biophys. Acta 1352:267-281(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-90; LYS-103 AND
RP   GLN-205.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   PRO-461.
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-46.
RX   PubMed=9700053; DOI=10.1023/A:1006813009006;
RA   Kelavkar U., Wang S., Montero A., Murtagh J., Shah K., Badr K.;
RT   "Human 15-lipoxygenase gene promoter: analysis and identification of
RT   DNA binding sites for IL-13-induced regulatory factors in monocytes.";
RL   Mol. Biol. Rep. 25:173-182(1998).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-16.
RX   PubMed=3356688;
RA   Sigal E., Grunberger D., Craik C.S., Caughey G.H., Nadel J.A.;
RT   "Arachidonate 15-lipoxygenase (omega-6 lipoxygenase) from human
RT   leukocytes. Purification and structural homology to other mammalian
RT   lipoxygenases.";
RL   J. Biol. Chem. 263:5328-5332(1988).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-31; 38-45; 157-168 AND 626-631.
RC   TISSUE=Eosinophil, and Leukocyte;
RX   PubMed=1662607; DOI=10.1111/j.1432-1033.1991.tb16495.x;
RA   Izumi T., Raadmark O., Joernvall H., Samuelsson B.;
RT   "Purification of two forms of arachidonate 15-lipoxygenase from human
RT   leukocytes.";
RL   Eur. J. Biochem. 202:1231-1238(1991).
RN   [10]
RP   CATALYTIC ACTIVITY, AND MUTAGENESIS OF MET-418.
RX   PubMed=1944593; DOI=10.1038/354149a0;
RA   Sloane D.L., Leung R., Craik C.S., Sigal E.;
RT   "A primary determinant for lipoxygenase positional specificity.";
RL   Nature 354:149-152(1991).
RN   [11]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9414270;
RA   Brinckmann R., Schnurr K., Heydeck D., Rosenbach T., Kolde G.,
RA   Kuehn H.;
RT   "Membrane translocation of 15-lipoxygenase in hematopoietic cells is
RT   calcium-dependent and activates the oxygenase activity of the
RT   enzyme.";
RL   Blood 91:64-74(1998).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11418015; DOI=10.1054/plef.2001.0263;
RA   Hsi L.C., Kamitani H., Cornicelli J.A., Eling T.E.;
RT   "Evaluation of the activity and localization of 15-lipoxygenase-1
RT   after introduction into human colorectal carcinoma Caco-2 cells.";
RL   Prostaglandins Leukot. Essent. Fatty Acids 64:217-225(2001).
RN   [13]
RP   LIPID-BINDING, SUBCELLULAR LOCATION, CATALYTIC ACTIVITY, FUNCTION, AND
RP   ENZYME REGULATION.
RX   PubMed=17052953; DOI=10.1016/j.bbalip.2006.09.007;
RA   Andersson E., Schain F., Svedling M., Claesson H.E., Forsell P.K.;
RT   "Interaction of human 15-lipoxygenase-1 with phosphatidylinositol
RT   bisphosphates results in increased enzyme activity.";
RL   Biochim. Biophys. Acta 1761:1498-1505(2006).
RN   [14]
RP   INDUCTION BY UV.
RX   PubMed=18755188; DOI=10.1016/j.febslet.2008.08.017;
RA   Yoo H., Jeon B., Jeon M.S., Lee H., Kim T.Y.;
RT   "Reciprocal regulation of 12- and 15-lipoxygenases by UV-irradiation
RT   in human keratinocytes.";
RL   FEBS Lett. 582:3249-3253(2008).
RN   [15]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19528634; DOI=10.1194/jlr.M900081-JLR200;
RA   Weibel G.L., Joshi M.R., Wei C., Bates S.R., Blair I.A.,
RA   Rothblat G.H.;
RT   "15(S)-Lipoxygenase-1 associates with neutral lipid droplets in
RT   macrophage foam cells: evidence of lipid droplet metabolism.";
RL   J. Lipid Res. 50:2371-2376(2009).
RN   [16]
RP   FUNCTION IN IL13 SIGNALING, INTERACTION WITH PEBP1, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=21831839; DOI=10.1073/pnas.1018075108;
RA   Zhao J., O'Donnell V.B., Balzar S., St Croix C.M., Trudeau J.B.,
RA   Wenzel S.E.;
RT   "15-Lipoxygenase 1 interacts with phosphatidylethanolamine-binding
RT   protein to regulate MAPK signaling in human airway epithelial cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:14246-14251(2011).
RN   [17]
RP   VARIANT MET-560, CHARACTERIZATION OF VARIANT MET-560, AND INVOLVEMENT
RP   IN CORONARY ARTERY DISEASE.
RX   PubMed=17959182; DOI=10.1016/j.atherosclerosis.2007.09.003;
RA   Assimes T.L., Knowles J.W., Priest J.R., Basu A., Borchert A.,
RA   Volcik K.A., Grove M.L., Tabor H.K., Southwick A., Tabibiazar R.,
RA   Sidney S., Boerwinkle E., Go A.S., Iribarren C., Hlatky M.A.,
RA   Fortmann S.P., Myers R.M., Kuhn H., Risch N., Quertermous T.;
RT   "A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and
RT   the risk of coronary artery disease.";
RL   Atherosclerosis 198:136-144(2008).
CC   -!- FUNCTION: Non-heme iron-containing dioxygenase that catalyzes the
CC       stereo-specific peroxidation of free and esterified
CC       polyunsaturated fatty acids generating a spectrum of bioactive
CC       lipid mediators. Converts arachidonic acid into 12-
CC       hydroperoxyeicosatetraenoic acid/12-HPETE and 15-
CC       hydroperoxyeicosatetraenoic acid/15-HPETE. Also converts linoleic
CC       acid to 13-hydroperoxyoctadecadienoic acid. May also act on (12S)-
CC       hydroperoxyeicosatetraenoic acid/(12S)-HPETE to produce hepoxilin
CC       A3. Probably plays an important role in the immune and
CC       inflammatory responses. Through the oxygenation of membrane-bound
CC       phosphatidylethanolamine in macrophages may favor clearance of
CC       apoptotic cells during inflammation by resident macrophages and
CC       prevent an autoimmune response associated with the clearance of
CC       apoptotic cells by inflammatory monocytes. In parallel, may
CC       regulate actin polymerization which is crucial for several
CC       biological processes, including macrophage function. May also
CC       regulate macrophage function through regulation of the peroxisome
CC       proliferator activated receptor signaling pathway. Finally, it is
CC       also involved in the cellular response to IL13/interleukin-13. In
CC       addition to its role in the immune and inflammatory responses, may
CC       play a role in epithelial wound healing in the cornea maybe
CC       through production of lipoxin A4. May also play a role in
CC       endoplasmic reticulum stress response and the regulation of bone
CC       mass. {ECO:0000269|PubMed:17052953, ECO:0000269|PubMed:21831839}.
CC   -!- CATALYTIC ACTIVITY: Arachidonate + O(2) = (5Z,8Z,10E,14Z)-(12S)-
CC       12-hydroperoxyicosa-5,8,10,14-tetraenoate.
CC       {ECO:0000269|PubMed:1944593}.
CC   -!- CATALYTIC ACTIVITY: Arachidonate + O(2) = (5Z,8Z,11Z,13E)-(15S)-
CC       15-hydroperoxyicosa-5,8,11,13-tetraenoate.
CC       {ECO:0000269|PubMed:17052953, ECO:0000269|PubMed:1944593}.
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00726};
CC       Note=Binds 1 Fe cation per subunit. {ECO:0000255|PROSITE-
CC       ProRule:PRU00726};
CC   -!- ENZYME REGULATION: Activity is increased by binding
CC       phosphatidylinositol phosphates, especially phosphatidylinositol
CC       3,4-bisphosphate and phosphatidylinositol 4,5-bisphosphate.
CC       {ECO:0000269|PubMed:17052953}.
CC   -!- PATHWAY: Lipid metabolism; hydroperoxy eicosatetraenoic acid
CC       biosynthesis.
CC   -!- SUBUNIT: Interacts with PEBP1; in response to IL13/interleukin-13,
CC       prevents the interaction of PEBP1 with RAF1 to activate the ERK
CC       signaling cascade. {ECO:0000269|PubMed:21831839}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cell membrane;
CC       Peripheral membrane protein. Lipid droplet. Note=Predominantly
CC       cytosolic; becomes enriched at membranes upon calcium binding.
CC       Translocates from the cytosol to the plasma membrane when
CC       stimulated by IL13/interleukin-13 and in macrophages binding
CC       apoptotic cells.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P16050-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P16050-2; Sequence=VSP_056681;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in monocytes and eosinophils (at
CC       protein level). Expressed in airway epithelial cells.
CC       {ECO:0000269|PubMed:21831839, ECO:0000269|PubMed:9414270}.
CC   -!- INDUCTION: Up-regulated by UV-irradiation.
CC       {ECO:0000269|PubMed:18755188}.
CC   -!- DOMAIN: The PLAT domain can bind calcium ions; this promotes
CC       association with membranes. {ECO:0000250}.
CC   -!- DISEASE: Note=Disease susceptibility may be associated with
CC       variations affecting the gene represented in this entry. Met at
CC       position 560 may confer interindividual susceptibility to coronary
CC       artery disease (CAD) (PubMed:17959182).
CC       {ECO:0000269|PubMed:17959182}.
CC   -!- SIMILARITY: Belongs to the lipoxygenase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ALOX15ID42986ch17p13.html";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/alox15/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M23892; AAA36182.1; -; mRNA.
DR   EMBL; U88317; AAB49305.1; -; Genomic_DNA.
DR   EMBL; AK290309; BAF82998.1; -; mRNA.
DR   EMBL; AK316126; BAH14497.1; -; mRNA.
DR   EMBL; AY505111; AAR84235.1; -; Genomic_DNA.
DR   EMBL; AC118754; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC029032; AAH29032.1; -; mRNA.
DR   EMBL; U63384; AAC52118.1; -; Genomic_DNA.
DR   CCDS; CCDS11049.1; -. [P16050-1]
DR   PIR; A31349; A31349.
DR   RefSeq; NP_001131.3; NM_001140.3. [P16050-1]
DR   UniGene; Hs.73809; -.
DR   PDB; 2ABT; Model; -; A=2-662.
DR   PDBsum; 2ABT; -.
DR   ProteinModelPortal; P16050; -.
DR   SMR; P16050; -.
DR   BioGrid; 106747; 4.
DR   DIP; DIP-60388N; -.
DR   STRING; 9606.ENSP00000293761; -.
DR   BindingDB; P16050; -.
DR   ChEMBL; CHEMBL2903; -.
DR   DrugBank; DB08492; (2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID.
DR   GuidetoPHARMACOLOGY; 1388; -.
DR   SwissLipids; SLP:000000667; -.
DR   iPTMnet; P16050; -.
DR   PhosphoSitePlus; P16050; -.
DR   BioMuta; ALOX15; -.
DR   DMDM; 126396; -.
DR   PaxDb; P16050; -.
DR   PeptideAtlas; P16050; -.
DR   PRIDE; P16050; -.
DR   Ensembl; ENST00000293761; ENSP00000293761; ENSG00000161905. [P16050-1]
DR   Ensembl; ENST00000570836; ENSP00000458832; ENSG00000161905. [P16050-1]
DR   Ensembl; ENST00000574640; ENSP00000460483; ENSG00000161905. [P16050-2]
DR   GeneID; 246; -.
DR   KEGG; hsa:246; -.
DR   UCSC; uc002fyh.4; human. [P16050-1]
DR   CTD; 246; -.
DR   DisGeNET; 246; -.
DR   GeneCards; ALOX15; -.
DR   HGNC; HGNC:433; ALOX15.
DR   HPA; CAB004962; -.
DR   HPA; CAB004963; -.
DR   HPA; HPA013859; -.
DR   MIM; 152392; gene.
DR   neXtProt; NX_P16050; -.
DR   OpenTargets; ENSG00000161905; -.
DR   PharmGKB; PA48; -.
DR   eggNOG; ENOG410IKAN; Eukaryota.
DR   eggNOG; ENOG410YN4N; LUCA.
DR   GeneTree; ENSGT00550000074415; -.
DR   HOVERGEN; HBG005150; -.
DR   InParanoid; P16050; -.
DR   KO; K00460; -.
DR   OMA; LTCWKDL; -.
DR   OrthoDB; EOG091G04A4; -.
DR   PhylomeDB; P16050; -.
DR   TreeFam; TF105320; -.
DR   BioCyc; MetaCyc:HS08621-MONOMER; -.
DR   BRENDA; 1.13.11.33; 2681.
DR   Reactome; R-HSA-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   Reactome; R-HSA-2142712; Synthesis of 12-eicosatetraenoic acid derivatives.
DR   Reactome; R-HSA-2142770; Synthesis of 15-eicosatetraenoic acid derivatives.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   SABIO-RK; P16050; -.
DR   UniPathway; UPA00881; -.
DR   GeneWiki; ALOX15; -.
DR   GenomeRNAi; 246; -.
DR   PRO; PR:P16050; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000161905; -.
DR   CleanEx; HS_ALOX15; -.
DR   ExpressionAtlas; P16050; baseline and differential.
DR   Genevisible; P16050; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005811; C:lipid particle; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0004052; F:arachidonate 12-lipoxygenase activity; IDA:UniProtKB.
DR   GO; GO:0050473; F:arachidonate 15-lipoxygenase activity; IDA:UniProtKB.
DR   GO; GO:0097260; F:eoxin A4 synthase activity; TAS:Reactome.
DR   GO; GO:0051120; F:hepoxilin A3 synthase activity; IEA:Ensembl.
DR   GO; GO:0047977; F:hepoxilin-epoxide hydrolase activity; IEA:Ensembl.
DR   GO; GO:0005506; F:iron ion binding; ISS:UniProtKB.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB.
DR   GO; GO:0043277; P:apoptotic cell clearance; ISS:UniProtKB.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0030282; P:bone mineralization; ISS:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB.
DR   GO; GO:0035963; P:cellular response to interleukin-13; IMP:UniProtKB.
DR   GO; GO:0051122; P:hepoxilin biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; TAS:ProtInc.
DR   GO; GO:0006691; P:leukotriene metabolic process; TAS:Reactome.
DR   GO; GO:2001303; P:lipoxin A4 biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0019372; P:lipoxygenase pathway; IDA:UniProtKB.
DR   GO; GO:0002820; P:negative regulation of adaptive immune response; ISS:UniProtKB.
DR   GO; GO:0001503; P:ossification; ISS:UniProtKB.
DR   GO; GO:0006646; P:phosphatidylethanolamine biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; ISS:UniProtKB.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IDA:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:1901074; P:regulation of engulfment of apoptotic cell; ISS:UniProtKB.
DR   GO; GO:0035358; P:regulation of peroxisome proliferator activated receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   GO; GO:0042060; P:wound healing; ISS:UniProtKB.
DR   Gene3D; 2.60.60.20; -; 1.
DR   InterPro; IPR000907; LipOase.
DR   InterPro; IPR013819; LipOase_C.
DR   InterPro; IPR020834; LipOase_CS.
DR   InterPro; IPR020833; LipOase_Fe_BS.
DR   InterPro; IPR001885; LipOase_mml.
DR   InterPro; IPR001024; PLAT/LH2_dom.
DR   PANTHER; PTHR11771; PTHR11771; 1.
DR   Pfam; PF00305; Lipoxygenase; 1.
DR   Pfam; PF01477; PLAT; 1.
DR   PRINTS; PR00087; LIPOXYGENASE.
DR   PRINTS; PR00467; MAMLPOXGNASE.
DR   SMART; SM00308; LH2; 1.
DR   SUPFAM; SSF48484; SSF48484; 1.
DR   SUPFAM; SSF49723; SSF49723; 1.
DR   PROSITE; PS00711; LIPOXYGENASE_1; 1.
DR   PROSITE; PS00081; LIPOXYGENASE_2; 1.
DR   PROSITE; PS51393; LIPOXYGENASE_3; 1.
DR   PROSITE; PS50095; PLAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell membrane;
KW   Complete proteome; Cytoplasm; Dioxygenase; Direct protein sequencing;
KW   Fatty acid metabolism; Iron; Lipid droplet; Lipid metabolism;
KW   Lipid-binding; Membrane; Metal-binding; Oxidoreductase; Polymorphism;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:1662607,
FT                                ECO:0000269|PubMed:3356688}.
FT   CHAIN         2    662       Arachidonate 15-lipoxygenase.
FT                                /FTId=PRO_0000220697.
FT   DOMAIN        2    114       PLAT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00152}.
FT   DOMAIN      115    662       Lipoxygenase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00726}.
FT   METAL       360    360       Iron; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00726}.
FT   METAL       365    365       Iron; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00726}.
FT   METAL       540    540       Iron; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00726}.
FT   METAL       544    544       Iron; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00726}.
FT   METAL       662    662       Iron; via carboxylate; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00726}.
FT   VAR_SEQ      46     84       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056681.
FT   VARIANT      90     90       D -> H (in dbSNP:rs11568142).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_018746.
FT   VARIANT     102    102       G -> V (in dbSNP:rs41439950).
FT                                /FTId=VAR_035036.
FT   VARIANT     103    103       N -> K (in dbSNP:rs11568099).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_018747.
FT   VARIANT     205    205       R -> Q (in dbSNP:rs11568101).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_018748.
FT   VARIANT     239    239       V -> M (in dbSNP:rs3892408).
FT                                /FTId=VAR_035037.
FT   VARIANT     461    461       A -> P (in dbSNP:rs17852628).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_035038.
FT   VARIANT     560    560       T -> M (loss of catalytic activity;
FT                                dbSNP:rs34210653).
FT                                {ECO:0000269|PubMed:17959182}.
FT                                /FTId=VAR_035039.
FT   MUTAGEN     418    418       M->V: Catalyzes 15- and 12-
FT                                lipoxygenation.
FT                                {ECO:0000269|PubMed:1944593}.
FT   CONFLICT     46     46       E -> V (in Ref. 7; AAC52118).
FT                                {ECO:0000305}.
SQ   SEQUENCE   662 AA;  74804 MW;  9ACF7FE7863A045C CRC64;
     MGLYRIRVST GASLYAGSNN QVQLWLVGQH GEAALGKRLW PARGKETELK VEVPEYLGPL
     LFVKLRKRHL LKDDAWFCNW ISVQGPGAGD EVRFPCYRWV EGNGVLSLPE GTGRTVGEDP
     QGLFQKHREE ELEERRKLYR WGNWKDGLIL NMAGAKLYDL PVDERFLEDK RVDFEVSLAK
     GLADLAIKDS LNVLTCWKDL DDFNRIFWCG QSKLAERVRD SWKEDALFGY QFLNGANPVV
     LRRSAHLPAR LVFPPGMEEL QAQLEKELEG GTLFEADFSL LDGIKANVIL CSQQHLAAPL
     VMLKLQPDGK LLPMVIQLQL PRTGSPPPPL FLPTDPPMAW LLAKCWVRSS DFQLHELQSH
     LLRGHLMAEV IVVATMRCLP SIHPIFKLII PHLRYTLEIN VRARTGLVSD MGIFDQIMST
     GGGGHVQLLK QAGAFLTYSS FCPPDDLADR GLLGVKSSFY AQDALRLWEI IYRYVEGIVS
     LHYKTDVAVK DDPELQTWCR EITEIGLQGA QDRGFPVSLQ ARDQVCHFVT MCIFTCTGQH
     ASVHLGQLDW YSWVPNAPCT MRLPPPTTKD ATLETVMATL PNFHQASLQM SITWQLGRRQ
     PVMVAVGQHE EEYFSGPEPK AVLKKFREEL AALDKEIEIR NAKLDMPYEY LRPSVVENSV
     AI
//
